EncrypGen, which specializes in blockchain for the genetic market, today announced strategic partnerships with Health Wizz and Codigo46.
NEW YORK (GenomeWeb) – EncrypGen, which specializes in blockchain for the genetic market, today announced strategic partnerships with Health Wizz and Codigo46.
Under the first partnership, EncrypGen and Health Wizz will work together to integrate EncrypGen’s Gene-Chain product — a private, permissioned blockchain for the secure transmission of de-identified genetic data — into the Health Wizz mobile platform, which provides consumers with tools to aggregate, manage, and share their medical data.
As part of the second partnership, EncrypGen will sell Codigo46’s genetic testing through the preferred vendor section of the EncrypGen website. The Codigo46 report is based on a non-invasive test that uses a buccal swab to obtain and analyze customers’ DNA to provide personalized information about disease risk, pharmacogenomics, and ancestry.
“Both developments are in anticipation of our imminent ‘MyGene-Chain’ service, which enables people to take control of their genomic data from testing to storage and to share it with their physicians,” EncrypGen CEO David Koepsell said in a statement.
